Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data.
Eagle Genomics has raised $3.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.
Eagle Genomics's investors include ETF Partners, Innovate UK, Future Planet Capital, Aberdeen, Midven.
Eagle Genomics is headquartered in Cambridge, United Kingdom.
Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data.
Eagle Genomics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eagle Genomics — Funding & Investors." VCBacked, September 27, 2023, https://www.vcbacked.co/company/eagle-genomics. Accessed October 18, 2026.
VCBacked. (2023). Eagle Genomics — Funding & Investors. Retrieved October 18, 2026, from https://www.vcbacked.co/company/eagle-genomics
{{cite web |title=Eagle Genomics — Funding & Investors |url=https://www.vcbacked.co/company/eagle-genomics |website=VCBacked |access-date=October 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated